Pr J.A. Sahel (chief of the «Institut de la Vision» — Inserm, CNRS, Université Paris VI), a member of the French Académie des Sciences, then presented a cell therapy phase I clinical trial
project for retinitis
pigmentosa developed in collaboration with I - Stem.